Form 4: Astrana Health Executive Adjusts Holdings

Chandan Basho, COO and CFO of Astrana Health, Inc., reported a transaction involving the surrender of shares to cover tax withholding obligations upon the vesting of restricted stock.

Summary

• Chandan Basho, the Chief Operating Officer and Chief Financial Officer of Astrana Health, Inc. (ASTH), has filed a Form 4 detailing a transaction on April 14, 2026.
• This transaction involved the surrender of 3,870 shares of common stock to offset tax withholding obligations related to the vesting of restricted stock on the same date.
• Following this transaction, Basho beneficially owns 167,765 shares of common stock.
• This ownership includes 30,404 unvested shares of restricted stock scheduled to vest in two equal annual installments on May 16, 2026, and May 16, 2027.
• Additionally, the ownership includes restricted stock units (RSUs) totaling 35,631 shares: 15,604 RSUs vesting in four semi-annual installments starting October 2, 2026, and 20,027 RSUs vesting in six semi-annual installments starting September 5, 2026.
• All vesting is contingent upon continuous employment with Astrana Health.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard administrative transaction related to executive compensation and does not provide new financial information or strategic direction.

Positives

• The transaction reflects a standard procedure for managing tax liabilities associated with equity compensation, indicating normal operational processes.
• The continued vesting schedule for restricted stock and RSUs suggests ongoing commitment and incentive alignment for key management personnel.
• Basho's substantial beneficial ownership of 167,765 shares indicates significant personal investment in the company's performance.

Negatives

• The surrender of shares to cover tax withholding represents a reduction in the net shares received by the executive, although it is a common and expected practice.
• The vesting of a portion of the executive's equity is tied to future performance and continued employment, implying potential downside if these conditions are not met.

Risks

• The vesting of restricted stock and RSUs is subject to continuous employment, meaning any departure from the company before vesting dates would result in forfeiture of those awards.
• The value of the unvested equity is subject to market fluctuations and the company's future performance, posing a risk to the executive's potential future wealth.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports a past transaction and details the vesting schedules for outstanding equity awards, which are contingent on continued employment.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for publicly traded companies, providing transparency into insider transactions. The details of Chandan Basho's equity holdings and vesting schedules are typical for senior executives in the healthcare technology sector, reflecting standard compensation and incentive structures.

Stakeholder Impact

• Shareholders: Increased transparency into executive compensation and potential future dilution from RSU vesting.
• Employees: Reinforces the importance of continued employment for equity award vesting.
• Management: Demonstrates adherence to disclosure requirements and management of equity compensation.

Next Steps

• Continued employment with Astrana Health, Inc. to meet vesting conditions for restricted stock and RSUs.
• Potential future transactions by Chandan Basho as equity awards vest or as per his personal financial planning.

Key Dates

Keywords

Form 4, SEC Filing, Chandan Basho, Astrana Health, ASTH, Insider Transaction, Stock Vesting, Restricted Stock, RSU, Tax Withholding, Beneficial Ownership, COO, CFO